
John Farleya, Laurent Ozbunb, Goli Samimic and Michael J. Birrerb,∗ Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences 4301 Jones Bridge Road, Bethesda, MD 20814, USA Cell and Cancer Biology Department, Medicine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA Cancer Prevention Fellowship Program and Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
Ovarian Neoplasms, Cell Cycle, Receptor Protein-Tyrosine Kinases, Cell Cycle Proteins, MAP Kinase Kinase Kinases, Prognosis, Biomarkers, Tumor, Humans, Female, Genes, Tumor Suppressor, Other
Ovarian Neoplasms, Cell Cycle, Receptor Protein-Tyrosine Kinases, Cell Cycle Proteins, MAP Kinase Kinase Kinases, Prognosis, Biomarkers, Tumor, Humans, Female, Genes, Tumor Suppressor, Other
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
